Here's Why Becton Dickinson (BDX) is a Strong Growth Stock

Company Overview - Becton, Dickinson and Company (BDX) is a medical technology company based in Franklin Lakes, NJ, primarily engaged in the development, manufacture, and sale of medical devices, instrument systems, and reagents [10]. Investment Ratings - BDX currently holds a Zacks Rank of 3 (Hold) with a VGM Score of B, indicating a moderate investment outlook [10]. - The company is considered a potential top pick for growth investors, with a Growth Style Score of B, forecasting year-over-year earnings growth of 7.3% for the current fiscal year [11]. Earnings Estimates - In the last 60 days, 10 analysts have revised their earnings estimates higher for fiscal 2024, with the Zacks Consensus Estimate increasing by $0.06 to $13.10 per share [11]. - BDX has an average earnings surprise of 6.2%, suggesting that the company has a history of exceeding earnings expectations [11].